The lateral flow, fingerprick blood test measures monoclonal proteins, with results that can be read on a phone app.

The test, which aids in the detection of the brain amyloid pathology characteristic of Alzheimer's, is the first blood test cleared by FDA for use in diagnosing the disease.

The partners will study the use of a test for Ly6E(hi) neutrophils as a biomarker for treatment response in five cancer indications.

Upfront will use the proceeds to accelerate the commercialization of its lateral flow test, called LVOne, for triaging stroke ...

The test detects the MET protein that is over-expressed in some patients with non-squamous non-small cell lung cancer.

NEW YORK — MDxHealth on Wednesday posted a 22 percent year-over-year increase in its first quarter revenues, topping Wall Street's consensus estimate. For the three-month period ended March 31, ...

EsoGuard esophageal precancer testing volume rose 25 percent to 3,034 tests in the first quarter compared to 2,420 tests in Q1 2024.

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

NEW YORK - Teal Health announced Friday that its self-collection device for human papillomavirus testing has obtained US Food and Drug Administration approval. The device can be used to collect ...

NEW YORK – Japanese digital pathology startup Medmain said on Thursday that it has raised $3.3 million through a third-party allotment of shares with investors. The funding round was led by One ...